In our study, on CD3−CD16+CD56+ NK cells of CVID patients, the percentages of those with CD28+ were significantly higher (p: 0.008) than controls while CD28− NK cells were significantly decreased in CVID cases (p: 0.006) (Table 4). The gene discussed is NCAM1; the disease is common variable immunodeficiency.